2019冠状病毒病对英国主要经皮冠状动脉介入治疗中心的影响：一项调查
Impact of COVID-19 on primary percutaneous coronary intervention centres in the UK: a survey.
作者信息
Adlan Ahmed M, Lim Ven G, Dhillon Gurpreet, Kurdi Hibba, Doolub Gemina, Elamin Nadir, Aziz Amir, Sastry Sanjay, Davis Gershan
机构信息
Senior Cardiology Fellow in Electrophysiology and Devices North West Heart Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT.
Cardiology Specialist Registrar University Hospital, University Hospitals Coventry & Warwickshire NHS Trust, Clifford Bridge Road, Coventry, CV2 2DX.
出版信息
Br J Cardiol. 2020 Jun 11;27(2):17. doi: 10.5837/bjc.2020.017. eCollection 2020.
During the coronavirus disease (COVID-19) pandemic, the British Cardiovascular Society/British Cardiovascular Intervention Society and the British Heart Rhythm Society recommended to postpone non-urgent elective work and that primary percutaneous coronary intervention (PCI) should remain the treatment of choice for patients with ST-segment elevation myocardial infarction (STEMI). We sought to determine the impact of COVID-19 on the primary PCI service within the United Kingdom (UK). A survey of 43 UK primary PCI centres was performed and a significant reduction in the number of cath labs open was found (pre-COVID 3.6±1.8 . post-COVID 2.1±0.8; p<0.001) with only 64% of cath labs remained open during the COVID-19 pandemic. Primary PCI remained first-line treatment for STEMI in all centres surveyed.
在冠状病毒病（COVID-19）大流行期间，英国心血管学会/英国心血管介入学会以及英国心律学会建议推迟非紧急择期手术，并指出对于ST段抬高型心肌梗死（STEMI）患者，直接经皮冠状动脉介入治疗（PCI）仍应作为首选治疗方法。我们试图确定COVID-19对英国主要PCI服务的影响。对英国43个主要PCI中心进行了一项调查，发现开放的导管实验室数量显著减少（COVID-19之前为3.6±1.8，之后为2.1±0.8；p<0.001），在COVID-19大流行期间只有64%的导管实验室仍在开放。在所有接受调查的中心，直接PCI仍然是STEMI的一线治疗方法。
Zotero 插件